MktsMarkets

ProMIS Neurosciences Inc.
NASDAQ: PMNKey statistics
PMN News
Stories mentioning PMN from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 6,971 | 9,368 | 9,797 | 8,750 | 5,464 | 4,324 | 2,564 | 1,626 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 8,645 | 10,772 | 11,750 | 10,185 | 7,460 | 6,001 | 4,435 | 2,714 |
| Operating Income (Loss) | (8,645) | (10,772) | (11,750) | (10,185) | (7,460) | (6,001) | (4,435) | (2,714) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 401.00 | 112.00 | 31.00 | |||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (8,244) | (10,674) | (11,580) | (10,117) | (7,348) | (238.00) | 9,276 | (2,624) |
| Earnings Per Share (Basic) | (1.26) | (6.08) | (0.24) | (0.29) | (5.27) | (0.23) | 0.31 | (0.13) |
| Earnings Per Share (Diluted) | (1.26) | (6.08) | (0.24) | (0.29) | (5.27) | (0.22) | 0.31 | (0.13) |
| Weighted Average Shares Outstanding (Basic) | 6,528 | 1,757 | 48,834 | 34,851 | 1,394 | 1,037 | 30,024 | 19,771 |
| Weighted Average Shares Outstanding (Diluted) | 6,528 | 1,757 | 48,834 | 34,851 | 1,394 | 1,058 | 30,067 | 19,771 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About PMN
ProMIS Neurosciences Inc. (NASDAQ: PMN) is a stock listed on the Nasdaq Stock Market under the ticker symbol PMN. It last traded at $3.29 (Nov 13, 2026, 4:00 PM ET), down 5.5% on the day. That gives ProMIS Neurosciences a market capitalisation of $31.2M.
Over the past 52 weeks PMN has traded between $2.78 and $27.40.
For the quarter ended Mar 31, 2026 it reported a net loss of $8.2M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$8.2M |
| Dec 31, 2025 | — | -$10.7M |
| Sep 30, 2025 | — | -$11.6M |
| Jun 30, 2025 | — | -$10.1M |
From ProMIS Neurosciences’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…